Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).

Sorry, there's nothing here.

Cite this paper

@article{Printz2009ClinicalTO, title={Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).}, author={Carrie Printz}, journal={Cancer}, year={2009}, volume={115 20}, pages={4646} }